Under the QMSR, the FDA is looking not merely at whether individual procedures exist, but whether the overall quality system is capable of consistently producing safe and effective devices.
With February 2026 now behind us, the FDA’s Quality Management System Regulation (QMSR) is here. For medical device manufacturers, the question has shifted from “are we ready?” to “can we demonstrate it?”
Integrated solutions combining ERP, MES, and QMS functionalities are replacing standalone QMS software in quality assurance. This shift enables real-time data collection and improved quality control. Medical device contract manufacturers can use these systems to enhance their quality services and gain a competitive advantage beyond cost and scrap reduction.
Kalpita Mehta is a combination products and medical device expert at a top U.S. generic manufacturer. She specializes in developing complex pharmaceutical products like COVID-19 testing kits.